Variant report
Variant | nsv900823 |
---|---|
Chromosome Location | chr13:89420896-89488821 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:89446778..89447282-chr20:52691355..52691999,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190905553 | chr13:89433805-89433806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144972781 | chr13:89433817-89433818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530126163 | chr13:89433837-89433838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142159933 | chr13:89433881-89433882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560848928 | chr13:89433939-89433940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527832333 | chr13:89433948-89433949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs376996009 | chr13:89433963-89433964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs144362634 | chr13:89433978-89433979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555779885 | chr13:89434003-89434004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570746643 | chr13:89434017-89434018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531285969 | chr13:89434025-89434026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147830061 | chr13:89434057-89434058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115400711 | chr13:89434149-89434150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535444668 | chr13:89434198-89434199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374683803 | chr13:89440650-89440651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560283592 | chr13:89440655-89440656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111327559 | chr13:89440668-89440669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551814850 | chr13:89440690-89440691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190181807 | chr13:89440699-89440700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182623251 | chr13:89440710-89440711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370824967 | chr13:89440775-89440776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552658086 | chr13:89440874-89440875 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569263054 | chr13:89440903-89440904 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571133419 | chr13:89440989-89440990 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1415172 | chr13:89441013-89441014 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs138922672 | chr13:89441068-89441069 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs118003113 | chr13:89441109-89441110 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565842459 | chr13:89441117-89441118 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539649823 | chr13:89441174-89441175 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548518931 | chr13:89441189-89441190 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186938711 | chr13:89441225-89441226 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs371952870 | chr13:89441227-89441228 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189874098 | chr13:89441246-89441247 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111810012 | chr13:89441247-89441248 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570911751 | chr13:89441251-89441252 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537987295 | chr13:89441350-89441351 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182836138 | chr13:89441385-89441386 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147131244 | chr13:89441419-89441420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78651932 | chr13:89441501-89441502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534202580 | chr13:89441588-89441589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572257839 | chr13:89441604-89441605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546369417 | chr13:89441623-89441624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564560808 | chr13:89441642-89441643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188782800 | chr13:89441670-89441671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535572144 | chr13:89441707-89441708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201485212 | chr13:89441708-89441709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs561634631 | chr13:89441712-89441713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs193211903 | chr13:89441758-89441759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547671161 | chr13:89441769-89441770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565973825 | chr13:89441793-89441794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Breast cancer | 22522925 | CNVD |
Osteosarcoma | 21215367 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:89433800-89434200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
2 | chr13:89440600-89440800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr13:89440800-89441400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr13:89441400-89442400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr13:89442400-89442800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr13:89455000-89455600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr13:89469800-89470200 | Enhancers | Dnd41 | blood |